Estimating rare disease prevalence and costs in the USA: a cohort study approach using the Healthcare Cost Institute claims data

Overview of attention for article published in BMJ Public Health, February 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)

Mentioned by

twitter: 3 X users

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 532 followers.

RT @CBI_at_GWU: Estimating rare disease prevalence and costs in the USA: a cohort study approach using the Healthcare Cost Institute claims…

17 Feb 2024

Reply Repost Favourite

Our latest paper on rare diseases (RDs) has just been published! Read the full paper to learn more about our insights into rare diseases and the potential impact on healthcare practices and policies! (1/3) #RareDiseases #HealthcareResearch #DataAnalysis #P

16 Feb 2024

Reply Repost Favourite

RT @CBI_at_GWU: Estimating rare disease prevalence and costs in the USA: a cohort study approach using the Healthcare Cost Institute claims…

16 Feb 2024

Reply Repost Favourite

Estimating rare disease prevalence and costs in the USA: a cohort study approach using the Healthcare Cost Institute claims data Congratulations @RahnavardLab @GW_OVPR @GWpublichealth https://t.co/EqE6qp0nRO

15 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.